Posted by & filed under Women's Health.

In a recent report published in Cancer Epidemiology, Biomarkers & Prevention, molecular subtypes were important predictors of breast cancer mortality. According to the study, women with HER2-enriched tumors and luminal B subtypes had the poorest survival despite adjusting for important covariates. Read a summary of the study…